Macular Infarction Following Intravitreal Triamcinolone Injection for Treatment of Central Retinal Vein Occlusion
Journal of the Korean Ophthalmological Society
;
: 1804-1809, 2015.
Article
in Korean
| WPRIM
| ID: wpr-189979
ABSTRACT
PURPOSE:
To report a case of macular infarction following intravitreal triamcinolone injection for treatment of central retinal vein occlusion. CASESUMMARY:
A 75-year-old male visited our clinic for visual disturbance in his left eye and was diagnosed with macular infarction in his right eye. His medical history included type 2 diabetes, alcoholic liver cirrhosis, and hepatocellular carcinoma. After fundus examination, the patient was diagnosed with central vein occlusion with macular edema and intravitreal triamcinolone was administered to reduce edema. Within 1 week of treatment with the intravitreal injection, the patient experienced a significant decrease in visual acuity. Fluorescein angiogram showed an enlargement of the foveal avasacular zone, although optical coherence tomography (OCT) showed a decreased macular edema. Despite normalization of macular thickness on OCT and cessation of leakage on angiography, visual acuity remained at the same level during 2 months of follow-up.CONCLUSIONS:
Intravitreal anti-vascular endothelial growth factor injection as well as intravitreal triamcinolone injection can cause macular ischemia which should be considered with the adopted treatment regimen for patients with ischemic risk factors.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Retinal Vein
/
Veins
/
Triamcinolone
/
Triamcinolone Acetonide
/
Angiography
/
Visual Acuity
/
Macular Edema
/
Risk Factors
/
Follow-Up Studies
/
Endothelial Growth Factors
Type of study:
Etiology study
/
Observational study
/
Prognostic study
/
Risk factors
Limits:
Aged
/
Humans
/
Male
Language:
Korean
Journal:
Journal of the Korean Ophthalmological Society
Year:
2015
Type:
Article
Similar
MEDLINE
...
LILACS
LIS